In a previous study, a cardiomyocyte-specific PPARG deficiency in mice resulted in cardiac hypertrophy with preserved systolic function, primarily due to oxidative stress linked to mitochondrial damage, and this overexpression ultimately progressed to cardiac hypertrophy, dilation, and dysfunction within a few months [31,32]. Here, PPARG is linked to cardiac hypertrophy.